Publications by authors named "David Gentien"

Claim this Profile
N
Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.
Mathilde Filser, Jacob Torrejon, Kevin Merchadou, Christelle Dufour, Elodie Girard, David Gentien

Neuro Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons.
Marc Michel, Maryam Heidary, Anissa Mechri, Kévin Da Silva, Marine Gorse, David Gentien

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plakins are involved in the regulation of centrosome position in polarized epithelial cells.
Juliana Geay, Yoran Margaron, David Gentien, Fabien Reyal, Alain Puisieux

Biol Cell· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers.
Rania El-Botty, Sophie Vacher, Juliette Mainguené, Adrien Briaux, Sabrina Ibadioune, David Gentien

Mol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Fariba Nemati, Leanne de Koning, David Gentien, Franck Assayag, Emilie Henry

Curr Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.
David Gentien, Elnaz Saberi-Ansari, Nicolas Servant, Ariane Jolly, Pierre de la Grange

Cell Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of inter- and intra-keloid heterogeneity through analysis of dermal fibroblasts: A new insight in deciphering keloid physiopathology.
Kévin Serror, Lauren Ferrero, Françoise Boismal, Maxime Sintes, Manuel Thery, David Gentien

Exp Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
Hélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, Clarice S Groeneveld, Luc Cabel, David Gentien

Oncogene· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.
Jacqueline Fontugne, Jennifer Wong, Luc Cabel, Hélène Neyret-Kahn, Narjesse Karboul, David Gentien

J Pathol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference standards for gene fusion molecular assays on cytological samples: an international validation study.
Umberto Malapelle, Francesco Pepe, Pasquale Pisapia, Annalisa Altimari, Claudio Bellevicine, David Gentien

J Clin Pathol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation.
Linda Silina, Florent Dufour, Audrey Rapinat, Cécile Reyes, David Gentien

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology.
Qinghe Zeng, Christophe Klein, Stefano Caruso, Pascale Maille, Narmin Ghaffari Laleh, David Gentien

J Hepatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer.
Suzette Delaloge, Sylvain Dureau, Véronique D'Hondt, Isabelle Desmoulins, Pierre-Etienne Heudel, David Gentien

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic.
Mahasti Saghatchian, Marc Abehsera, Amina Yamgnane, Caroline Geyl, Emilien Gauthier, David Gentien

Breast Cancer Res Treat· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.
Cong Trung Nguyen, Stefano Caruso, Pascale Maille, Aurélie Beaufrère, Jérémy Augustin, David Gentien

Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer.
Nanor Sirab, Damien Drubay, Pascale Maillé, Tatiana Popova, Carine Ngo, David Gentien

J Pathol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer.
Samyuktha Suresh, Solène Huard, Amélie Brisson, Fariba Némati, Rayan Dakroub, David Gentien

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer.
Laetitia Marisa, Yuna Blum, Julien Taieb, Mira Ayadi, Camilla Pilati, David Gentien

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
Ivan Bièche, Florence Coussy, Rania El-Botty, Sophie Vacher, Sophie Château-Joubert, David Gentien

J Hematol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
Jing Liu, Daniela Ottaviani, Meriem Sefta, Céline Desbrousses, Elodie Chapeaublanc, David Gentien

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine.
Valentine Suteau, Valérie Seegers, Mathilde Munier, Rym Ben Boubaker, Cécile Reyes, David Gentien

J Clin Endocrinol Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.
Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi, David Gentien

NPJ Precis Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Multiplexed Gene Expression Analysis of mRNA and miRNA from Routinely Processed and Stained Cytological Smears: A Proof-of-Principle Study.
David Gentien, Laure Piqueret-Stephan, Emilie Henry, Benoît Albaud, Audrey Rapinat

Acta Cytol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of cancer stem cell markers and in colorectal cancer.
Bogdan Badic, Stéphanie Durand, Flaria El Khoury, Pierre De La Grange, David Gentien

Am J Transl Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
Elodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd, Ludivine Morisset, Rania El Botty, David Gentien

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis